AVLSA
VIGL
Atlas Venture Life Science Advisors’s Vigil Neuroscience VIGL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $46.4M | Hold |
5,836,874
| – | – | 7.01% | 6 |
|
|
2025
Q1 | $10.4M | Hold |
5,836,874
| – | – | 1.99% | 8 |
|
|
2024
Q4 | $9.92M | Hold |
5,836,874
| – | – | 1.21% | 7 |
|
|
2024
Q3 | $19.8M | Hold |
5,836,874
| – | – | 1.84% | 9 |
|
|
2024
Q2 | $23.3M | Hold |
5,836,874
| – | – | 2.46% | 9 |
|
|
2024
Q1 | $19.9M | Hold |
5,836,874
| – | – | 1.84% | 10 |
|
|
2023
Q4 | $19.7M | Hold |
5,836,874
| – | – | 2.35% | 8 |
|
|
2023
Q3 | $31.5M | Hold |
5,836,874
| – | – | 4.87% | 7 |
|
|
2023
Q2 | $54.9M | Hold |
5,836,874
| – | – | 6.83% | 5 |
|
|
2023
Q1 | $57.1M | Hold |
5,836,874
| – | – | 7.74% | 5 |
|
|
2022
Q4 | $73M | Hold |
5,836,874
| – | – | 8.79% | 4 |
|
|
2022
Q3 | $53.1M | Hold |
5,836,874
| – | – | 5.86% | 6 |
|
|
2022
Q2 | $15.1M | Hold |
5,836,874
| – | – | 2.52% | 9 |
|
|
2022
Q1 | $41M | Buy |
+5,836,874
| New | +$41M | 5.19% | 7 |
|